{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T08:27:22Z","timestamp":1769934442449,"version":"3.49.0"},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T00:00:00Z","timestamp":1548201600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004590","name":"Helse Midt-Norge","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004590","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0210997","type":"journal-article","created":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T20:41:00Z","timestamp":1548276060000},"page":"e0210997","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":28,"title":["Clinical performance of Anyplex II HPV28 by human papillomavirus type and viral load in a referral population"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0688-8031","authenticated-orcid":true,"given":"Ingrid","family":"Baasland","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u00e5l R.","family":"Romundstad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maj Liv","family":"Eide","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine M.","family":"Jonassen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2019,1,23]]},"reference":[{"key":"ref1","unstructured":"IARC. Monographs on the evaluation of carcinogenic risks to humans, vol 100B, p. 255\u2013296 Lyon: IARC; 2012 [cited 2018 03.09.]. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/monographs.iarc.fr\/wp-content\/uploads\/2018\/06\/mono100B-11.pdf\" xlink:type=\"simple\">https:\/\/monographs.iarc.fr\/wp-content\/uploads\/2018\/06\/mono100B-11.pdf<\/ext-link>."},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ygyno.2017.10.031","article-title":"HPV genotype profile in a Norwegian cohort with ASC-US and LSIL cytology with three year cumulative risk of high grade cervical neoplasia","volume":"148","author":"AK Lie","year":"2018","journal-title":"Gynecologic oncology"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.pvr.2016.05.004","article-title":"Need for expanded HPV genotyping for cervical screening","volume":"2","author":"J Cuzick","year":"2016","journal-title":"Papillomavirus research (Amsterdam, Netherlands)"},{"issue":"Suppl 3","key":"ref4","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S1386-6532(09)00540-X","article-title":"Validation of high-risk HPV tests for primary cervical screening","volume":"46","author":"CJ Meijer","year":"2009","journal-title":"J Clin Virol"},{"issue":"3","key":"ref5","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/ijc.24010","article-title":"Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older","volume":"124","author":"CJ Meijer","year":"2009","journal-title":"International journal of cancer"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jviromet.2015.02.018","article-title":"Performance evaluation of AnyplexII HPV28 detection kit in a routine diagnostic setting: comparison with the HPV Sign(R) Genotyping Test","volume":"217","author":"F Marcuccilli","year":"2015","journal-title":"J Virol Methods"},{"issue":"2","key":"ref7","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1128\/JCM.02749-13","article-title":"Comparison of Seegene Anyplex II HPV28 with the PGMY-CHUV assay for human papillomavirus genotyping","volume":"52","author":"C Estrade","year":"2014","journal-title":"Journal of clinical microbiology"},{"issue":"4","key":"ref8","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jcv.2014.01.015","article-title":"Comparison of the Anyplex II HPV28 assay with the Hybrid Capture 2 assay for the detection of HPV infection","volume":"59","author":"MJ Kwon","year":"2014","journal-title":"J Clin Virol"},{"issue":"3","key":"ref9","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.diagmicrobio.2016.04.011","article-title":"Analytical performance evaluation of Anyplex II HPV28 and Euroarray HPV for genotyping of cervical samples","volume":"85","author":"A Latsuzbaia","year":"2016","journal-title":"Diagn Microbiol Infect Dis"},{"key":"ref10","article-title":"Comparison of Three Different Commercial Kits for the Human Papilloma Virus Genotyping","author":"YK Lim","year":"2016","journal-title":"J Clin Lab Anal"},{"issue":"11","key":"ref11","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1111\/aogs.13009","article-title":"Colposcopy and additive diagnostic value of biopsies from colposcopy-negative areas to detect cervical dysplasia","volume":"95","author":"I Baasland","year":"2016","journal-title":"Acta obstetricia et gynecologica Scandinavica"},{"key":"ref12","unstructured":"Norsk gynekologisk forening. Veileder i gynekologisk onkologi: Premaligne lidelser i cervix: Norsk gynekologisk forening; 2009 [cited 2015 05.01.]. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/legeforeningen.no\/Fagmed\/Norsk-gynekologisk-forening\/Veiledere\/veileder-i-gynekologisk-onkologi-2009\/premaligne-lidelser-i-cervix\/\" xlink:type=\"simple\">http:\/\/legeforeningen.no\/Fagmed\/Norsk-gynekologisk-forening\/Veiledere\/veileder-i-gynekologisk-onkologi-2009\/premaligne-lidelser-i-cervix\/<\/ext-link>."},{"issue":"8","key":"ref13","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1128\/JCM.01863-08","article-title":"Performance of human papillomavirus DNA and mRNA testing strategies for women with and without cervical neoplasia","volume":"47","author":"A Trope","year":"2009","journal-title":"Journal of clinical microbiology"},{"issue":"Suppl 10","key":"ref14","doi-asserted-by":"crossref","first-page":"K1","DOI":"10.1016\/j.vaccine.2008.05.064","article-title":"Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia","volume":"26","author":"FX Bosch","year":"2008","journal-title":"Vaccine"},{"issue":"6","key":"ref15","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1128\/JCM.00181-12","article-title":"Comparison of seven tests for high-grade cervical intraepithelial neoplasia in women with abnormal smears: the Predictors 2 study","volume":"50","author":"A Szarewski","year":"2012","journal-title":"Journal of clinical microbiology"},{"issue":"8","key":"ref16","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1128\/JCM.00382-10","article-title":"Clinical performance of the PreTect HPV-Proofer E6\/E7 mRNA assay in comparison with that of the Hybrid Capture 2 test for identification of women at risk of cervical cancer","volume":"48","author":"S Ratnam","year":"2010","journal-title":"Journal of clinical microbiology"},{"issue":"4","key":"ref17","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/path.4424","article-title":"Are 20 human papillomavirus types causing cervical cancer?","volume":"234","author":"M Arbyn","year":"2014","journal-title":"The Journal of pathology"},{"key":"ref18","article-title":"Pathology and genetics of tumours of the breast and female genital organs (World Health Organization classification of tumours; 5)","author":"FA Tavassoli","year":"2003"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","article-title":"The measurement of observer agreement for categorical data","volume":"33","author":"JR Landis","year":"1977","journal-title":"Biometrics"},{"issue":"11","key":"ref20","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1158\/1055-9965.EPI-08-0508","article-title":"Comparison of predictors for high-grade cervical intraepithelial neoplasia in women with abnormal smears","volume":"17","author":"A Szarewski","year":"2008","journal-title":"Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology"},{"issue":"3","key":"ref21","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.ygyno.2014.03.552","article-title":"Cervical cytology and multiple type HPV infection: a study of 8182 women ages 31\u201365","volume":"133","author":"EL Dickson","year":"2014","journal-title":"Gynecologic oncology"},{"key":"ref22","article-title":"Comparison of the performance of Anyplex II HPV HR, the Cobas 4800 human papillomavirus test and Hybrid Capture 2","author":"DH Lee","year":"2015","journal-title":"Ann Clin Biochem"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jcv.2016.01.009","article-title":"Clinical validation of Anyplex II HPV HR Detection according to the guidelines for HPV test requirements for cervical cancer screening","volume":"76","author":"AT Hesselink","year":"2016","journal-title":"J Clin Virol"},{"issue":"3","key":"ref24","doi-asserted-by":"crossref","first-page":"276","DOI":"10.5858\/arpa.2015-0117-OA","article-title":"Clinical Validation of Anyplex II HPV HR Detection Test for Cervical Cancer Screening in Korea","volume":"140","author":"S Jung","year":"2016","journal-title":"Arch Pathol Lab Med"},{"issue":"12","key":"ref25","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.1128\/JCM.01231-12","article-title":"Clinical validation of a type-specific real-time quantitative human papillomavirus PCR against the performance of hybrid capture 2 for the purpose of cervical cancer screening","volume":"50","author":"CE Depuydt","year":"2012","journal-title":"Journal of clinical microbiology"},{"issue":"8","key":"ref26","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1002\/cam4.473","article-title":"Serial type-specific human papillomavirus (HPV) load measurement allows differentiation between regressing cervical lesions and serial virion productive transient infections","volume":"4","author":"CE Depuydt","year":"2015","journal-title":"Cancer medicine"},{"issue":"1","key":"ref27","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3201\/eid2201.150736","article-title":"Human Papillomavirus Prevalence and Herd Immunity after Introduction of Vaccination Program, Scotland, 2009\u20132013","volume":"22","author":"RL Cameron","year":"2016","journal-title":"Emerging infectious diseases"},{"issue":"11","key":"ref28","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1038\/bjc.2014.198","article-title":"Introduction and sustained high coverage of the HPV bivalent vaccine leads to a reduction in prevalence of HPV 16\/18 and closely related HPV types","volume":"110","author":"K Kavanagh","year":"2014","journal-title":"British journal of cancer"},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1158\/1055-9965.EPI-14-0566","article-title":"Evaluation of human papillomavirus type replacement postvaccination must account for diagnostic artifacts: masking of HPV52 by HPV16 in anogenital specimens","volume":"24","author":"JE Tota","year":"2015","journal-title":"Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology"},{"key":"ref30","unstructured":"Enges\u00e6ther B NM, Trope`A. Implementering av HPV-test i prim\u00e6rscreening \u2022 Anbefaling av videre screeningstrategi for kvinner med cytologisk vurdering i f\u00f8rste screeningrunde \u2022 Refleksjoner rundt nasjonal implementering Cancer Registry of Norway: Cancer Registry of Norway; 2017."},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.diagmicrobio.2016.08.022","article-title":"Comparison of Cobas(R) HPV and Anyplex II HPV28 assays for detecting and genotyping human papillomavirus","volume":"87","author":"C Pasquier","year":"2017","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"11","key":"ref32","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01176-18","article-title":"Clinical and Analytical Evaluation of the Anyplex II HPV HR Detection Assay within the VALGENT-3 Framework","volume":"56","author":"A Ostrbenk","year":"2018","journal-title":"Journal of clinical microbiology"},{"issue":"1","key":"ref33","doi-asserted-by":"crossref","first-page":"e0115960","DOI":"10.1371\/journal.pone.0115960","article-title":"Comparison of eleven methods for genomic DNA extraction suitable for large-scale whole-genome genotyping and long-term DNA banking using blood samples","volume":"10","author":"A Psifidi","year":"2015","journal-title":"PloS one"},{"issue":"3","key":"ref34","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S1383-5742(02)00090-X","article-title":"Biological sample collection and processing for molecular epidemiological studies","volume":"543","author":"NT Holland","year":"2003","journal-title":"Mutation research"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0210997","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T03:54:51Z","timestamp":1588996491000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0210997"}},"subtitle":[],"editor":[{"given":"Charlotte","family":"Charpentier","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2019,1,23]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,1,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0210997","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,23]]}}}